215 related articles for article (PubMed ID: 9098478)
1. Incidence of Chlamydia trachomatis in women with PID: effectiveness of therapy.
De Punzio C; Neri E; Guazzelli G; Gremigni R
Acta Eur Fertil; 1995; 26(4):149-51. PubMed ID: 9098478
[TBL] [Abstract][Full Text] [Related]
2. Preventing infective sequelae of abortion.
Penney GC
Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
[TBL] [Abstract][Full Text] [Related]
3. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review.
Risser WL; Risser JM
Int J STD AIDS; 2007 Nov; 18(11):727-31. PubMed ID: 18005504
[TBL] [Abstract][Full Text] [Related]
4. [Our experience with the treatment of Chlamydia trachomatis in acute and chronic inflammatory diseases of the female genitalia].
Karadzhova R; Chamova M; Borisov I; Krutilin S; Tsoneva V
Akush Ginekol (Sofiia); 1990; 29(6):22-5. PubMed ID: 2100948
[TBL] [Abstract][Full Text] [Related]
5. Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease.
Trent M; Chung SE; Forrest L; Ellen JM
Arch Pediatr Adolesc Med; 2008 Nov; 162(11):1022-5. PubMed ID: 18981349
[TBL] [Abstract][Full Text] [Related]
6. [Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin ].
Colombo U; Pifarotti G; Amidani M; Viezzoli T; Pifarotti P
Minerva Ginecol; 1998 Nov; 50(11):491-7. PubMed ID: 9882991
[TBL] [Abstract][Full Text] [Related]
7. Significance of cervical Chlamydia trachomatis infection in postabortal pelvic inflammatory disease.
Westergaard L; Philipsen T; Scheibel J
Obstet Gynecol; 1982 Sep; 60(3):322-5. PubMed ID: 7121913
[TBL] [Abstract][Full Text] [Related]
8. Screening for chlamydial infections in women with pelvic inflammatory diseases.
Chowdhary A; Malhotra VL; Deb M; Rai U
J Commun Dis; 1998 Sep; 30(3):163-6. PubMed ID: 10093422
[TBL] [Abstract][Full Text] [Related]
9. Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.
Tamarelle J; Thiébaut ACM; Sabin B; Bébéar C; Judlin P; Fauconnier A; Rahib D; Méaude-Roufai L; Ravel J; Morré SA; de Barbeyrac B; Delarocque-Astagneau E;
Trials; 2017 Nov; 18(1):534. PubMed ID: 29132441
[TBL] [Abstract][Full Text] [Related]
10. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
Heinonen PK; Leinonen M
Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
[TBL] [Abstract][Full Text] [Related]
11. Pelvic inflammatory disease: etiologic studies with emphasis on chlamydial infection.
Gjønnaess H; Dalaker K; Anestad G; Mårdh PA; Kvile G; Bergan T
Obstet Gynecol; 1982 May; 59(5):550-5. PubMed ID: 6803199
[TBL] [Abstract][Full Text] [Related]
12. Pelvic inflammatory disease in the People's Republic of China: aetiology and management.
Hong S; Xin C; Qianhong Y; Yanan W; Wenyan X; Peeling RW; Mabey D
Int J STD AIDS; 2002 Aug; 13(8):568-72. PubMed ID: 12194742
[TBL] [Abstract][Full Text] [Related]
13. Recommendations and rationale for the treatment of pelvic inflammatory disease.
Jaiyeoba O; Lazenby G; Soper DE
Expert Rev Anti Infect Ther; 2011 Jan; 9(1):61-70. PubMed ID: 21171878
[TBL] [Abstract][Full Text] [Related]
14. Tubal factor pathology caused by Chlamydia trachomatis: the role of serology.
Mouton JW; Peeters MF; van Rijssort-Vos JH; Verkooyen RP
Int J STD AIDS; 2002 Dec; 13 Suppl 2():26-9. PubMed ID: 12537722
[TBL] [Abstract][Full Text] [Related]
15. Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade.
Sørbye IK; Jerve F; Staff AC
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):290-6. PubMed ID: 15715539
[TBL] [Abstract][Full Text] [Related]
16. Incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis.
Aghaizu A; Atherton H; Mallinson H; Simms I; Kerry S; Oakeshott P; Hay PE
Int J STD AIDS; 2008 Apr; 19(4):283. PubMed ID: 18482953
[No Abstract] [Full Text] [Related]
17. A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease.
Soper DE; Despres B
Obstet Gynecol; 1988 Jul; 72(1):7-12. PubMed ID: 3132668
[TBL] [Abstract][Full Text] [Related]
18. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.
Morré SA; van den Brule AJ; Rozendaal L; Boeke AJ; Voorhorst FJ; de Blok S; Meijer CJ
Int J STD AIDS; 2002 Dec; 13 Suppl 2():12-8. PubMed ID: 12537719
[TBL] [Abstract][Full Text] [Related]
19. Detection of Chlamydia trachomatis antigen by enzyme immunoassay in patients with pelvic inflammatory disease.
Lal H; Rathee S; Sharma D; Chaudhary S
Indian J Med Res; 1992 Mar; 95():77-8. PubMed ID: 1601474
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Chalmydia trachomatis infection amongst patients with pelvic inflammatory diseases and infertility.
Vidhani S; Mehta S; Bhalla P; Bhalla R; Sharma VK; Batra S
J Commun Dis; 2005 Sep; 37(3):233-8. PubMed ID: 17080708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
